Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
EXSCEL, exenatide study of cardiovascular event lowering trial
2-deoxy-2-[fluorine-18] fluoro-d-glucose ([18 F]-FDG) (Dongcheng AMS Pharmaceutical atom, Shanghai, China) was injected into the tail vein at a dose of ~3.7 MBq/10 g body weight (0.1 mCi/10 g)
Keeping vials sealed and allowing cold vials to reach room temperature before opening can help reduce condensation risk
Side effects peak as doses increase toward maintenance levels
10.1124/mol.120.119693 146 WangY.ZhangS.XieX.ChenZ.WuL.YuZ.et al (2019)
US$ 21.43
US$ 23.77
US$ 26.55
US$ 25.68
US$ 29.05
